At long last, the mystery regarding $3.2 M sales has been resolved .
Has anyone noticed that there is another entity called Solathera ?
This entity is used for trading outside Russia (ie. it buys stuff from Russia and sells in rest of World (excluding Russia).
If one notes that in this half year - Solagran has loaned it another $4,669,780 bringing total loan to $9,632,264
This entity buys stuff from sibEX (and other Russian organisation - previously from Solana etc) - so it has bought $3.2 M stuff from SibEX.
As directors have already declared pricing for Ropren for rest of the world (between $3,500 to $6,000 per course), Solathera is free to sell outside Russia and it has done so (but money has not been received as yet - ie receiveables). You may also note that Inventories and finished goods are part of Solethera's capital.
This information has been deduced from looking at and interpreting this year and last year's reports.
As there are three entities involved (Solagran, Solathera and SibEX), it is extremely difficult (if not impossible) to interpret things unless one has reports for all three!!
Stay Tuned!!
SLA Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)